section name header

Information

Osteonecrosis, Charcot joint, rheumatoid arthritis, psoriatic arthritis, crystal-induced arthritides.

Treatment: Osteoarthritis

  • Treatment goal—alleviate pain and minimize loss of physical function.
  • Nonpharmacotherapy strategies aimed at altering loading across the painful joint—include pt education, weight reduction, appropriate use of cane and other supports, isometric exercises to strengthen muscles around affected joints, bracing/orthotics to correct malalignment.
  • Topical capsaicin cream may help relieve hand or knee pain.
  • Acetaminophen—commonly used analgesic, caution regarding hepatic toxicity.
  • NSAIDs, COX-2 inhibitors—GI, renal, cardiovascular toxicity, must weigh individual risks and benefits.
  • Topical NSAIDs—fewer GI and systemic side effects; can cause skin irritation
  • Opioid analgesics—may be considered in selected pts whose symptoms are inadequately controlled with other measures and who cannot undergo surgery; habituation is a potential concern.
  • Intraarticular glucocorticoids—may provide symptomatic relief but typically short-lived.
  • Intraarticular hyaluronan—can be given for symptomatic knee and hip OA, but it is controversial whether it has efficacy beyond placebo.
  • Glucosamine and chondroitin—large scale trials have failed to show efficacy for pain relief; recent guidelines recommend against use.
  • Systemic glucocorticoids have no place in the treatment of OA.
  • Arthroscopic debridement and lavage—randomized trials have shown no greater effect on pain relief or disability compared to sham procedure or no treatment.
  • Joint replacement surgery may be considered in pts with advanced OA who have intractable pain and loss of function in whom aggressive medical management has failed.

For a more detailed discussion, see Felson DT: Osteoarthritis, Chap. 394, p. 2226, in HPIM-19.

Outline

Section 12. Allergy, Clinical Immunology, and Rheumatology